Delivery Order SPE2DB20D3103-SPE2DB22FM8W5
- Not listed
- This federal contract award, valued at $22,065.68, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The award is for the delivery of Lotrel 10-20 mg capsules, a cardiovascular medication, to support military healthcare programs. The contract has a completion date of May 16, 2023 and is a firm fixed-price delivery order. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that has received numerous contracts from the...
- This federal contract award, valued at $24,980.73, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The award is a delivery order under the DLA's Indefinite Delivery Contract (IDC) with Amerisourcebergen, valued at up to $999,999,999.00 and running through November 2026. This IDC serves as the primary vehicle for Amerisourcebergen to supply a comprehensive range of pharmaceutical products and medical supplies, including...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The $1,023.63 firm fixed-price delivery order is for the supply of 100 capsules of the medication Lotrel 5-10 mg. The contract has an ultimate completion date of July 14, 2025 and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite...
- This federal contract award, valued at $5,172.23, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is a delivery order to supply Lotrel 10-20 mg capsules, a cardiovascular medication, to support federal healthcare programs. The award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Lotrel 10-20 mg capsules. The contract has a ceiling value of $3,753.90 and an ultimate completion date of August 15, 2023. It is a firm fixed-price delivery order contract, with no set-aside designation. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which also holds significant Indefinite...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $14,741.48 firm fixed-price delivery order is for the supply of LOTREL 10-20 MG CAPSULE 100S, a cardiovascular medication. The contract has an ultimate completion date of November 22, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,130.61 Firm Fixed Price Delivery Order contract is for the supply of LOTREL 5-20 MG CAPSULE 100S, a cardiovascular medication. The contract has a completion date of February 10, 2023. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite...
- This federal contract award, valued at $33,589.39, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of LOTREL 10-20 MG CAPSULE 100S, a cardiovascular medication. This award is associated with a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through...
- This federal contract award, valued at $9,262.99, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of LOTREL 10-20 MG CAPSULE 100S, a cardiovascular medication, with a completion date of September 19, 2023. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., which holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This is a federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., by the Defense Logistics Agency (DLA). The contract is for the delivery of Lotrel 5-20 mg capsules, a cardiovascular medication, with a ceiling value of $1,324.36 and a completion date of April 14, 2023. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB22FM8W5Delivery Order
This federal contract award, valued at $33,506.30, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract covers the delivery of 4,556,447,587 units of the cardiovascular medication Lotrel 10-20 mg capsules in 100-count bottles. This is a firm-fixed-price delivery order contract, with a completion date of March 4, 2022. The contract was awarded on an unrestricted, full and open competition basis, with no set-aside designations. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026. This IDC serves as a primary vehicle for the company to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. Additionally, Cencora, Inc. maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation through May 2024, covering similar medical commodities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $33.5k | 3/3/22 |